XIAP and inflammatory breast carcinoma: In addition, our data (shXIAP-GFP; Figure 5C) show that the knock down of XIAP (inhibitor of programmed cell death), implicated in aggressive IBC progression [22,43,44], suppressed migration in the window chamber model compared to an isogenic-matched parental IBC cell line.